• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用宏观特征和年龄的晚期胃癌简易预后指标

Simple prognostic indicators using macroscopic features and age in advanced gastric cancer.

作者信息

Yamashita Keishi, Sakuramoto Shinichi, Katada Natsuya, Kikuchi Shiro, Watanabe Masahiko

出版信息

Hepatogastroenterology. 2014 Mar-Apr;61(130):512-7.

PMID:24901173
Abstract

BACKGROUND/AIM: Macroscopic features and age may be important prognostic factors that discriminate survival among clinical conditions requiring different therapeutic strategies of advanced gastric cancer (AGC), and this study aimed to identify their clinical relevance.

METHODOLOGY

A total of 232 AGC patients who had Surgical T2b or beyond was enrolled to identify clinical indicators, including macroscopic features in combination with age.

RESULTS

Macroscopic features were divided into 3 categories (types I/II/V, III, and IV), which included stage IV in 24%, 53%, and 72% (P < 0.0001), respectively. Macroscopic features (P < 0.0001), histological features (P = 0.025), and pathological infiltration type (P = 0.0003) were all univariate prognostic factors, as well as stage (P < 0.0001) and age (P = 0.009). However, the multivariate proportional hazards model found that macroscopic features (P = 0.0013) and age (P = 0.0091) were the only factors independent of stage (P <0.0001). Both factors clearly classified the patients into 4 groups (young type 1/II/V (group 1), elderly type I/II/V (group 2), type III and young type IV (group 3), and elderly type IV (group 4) with different prognoses.

CONCLUSIONS

Macroscopic features and age were simple indicators of prognosis in AGC. Both factors may have great potential to develop prognostic categories that effectively classify AGC into categories requiring different therapeutic strategies.

摘要

背景/目的:宏观特征和年龄可能是区分需要不同治疗策略的晚期胃癌(AGC)临床状况下生存情况的重要预后因素,本研究旨在确定它们的临床相关性。

方法

共纳入232例手术T2b及以上的AGC患者,以确定临床指标,包括宏观特征与年龄的组合。

结果

宏观特征分为3类(I/II/V型、III型和IV型),IV期分别占24%、53%和72%(P<0.0001)。宏观特征(P<0.0001)、组织学特征(P=0.025)和病理浸润类型(P=0.0003)均为单因素预后因素,分期(P<0.0001)和年龄(P=0.009)也是。然而,多变量比例风险模型发现,宏观特征(P=0.0013)和年龄(P=0.0091)是独立于分期(P<0.0001)的唯一因素。这两个因素都将患者明确分为4组(年轻的I/II/V型(第1组)、老年的I/II/V型(第2组)、III型和年轻的IV型(第3组)以及老年的IV型(第4组)),预后不同。

结论

宏观特征和年龄是AGC预后的简单指标。这两个因素都可能有很大潜力开发预后分类,有效地将AGC分为需要不同治疗策略的类别。

相似文献

1
Simple prognostic indicators using macroscopic features and age in advanced gastric cancer.利用宏观特征和年龄的晚期胃癌简易预后指标
Hepatogastroenterology. 2014 Mar-Apr;61(130):512-7.
2
Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.弥漫型进展期胃癌预后不佳,其特征为浸润更深且出现腹膜癌细胞:与肠型进展期胃癌的最新对比研究。
Hepatogastroenterology. 2009 Jan-Feb;56(89):276-81.
3
[Clinicopathologic features and prognostic analyses of Borrmann type IV gastric cancer].[Borrmann Ⅳ型胃癌的临床病理特征及预后分析]
Zhonghua Yi Xue Za Zhi. 2012 Sep 25;92(36):2534-7.
4
Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.胃中三分之一腺癌——临床病理特征预后意义的评估
Hepatogastroenterology. 1997 Sep-Oct;44(17):1488-94.
5
Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients.胃癌患者年龄的临床病理特征及预后价值:对3362例连续胃癌患者的分析
J Surg Oncol. 2009 Jun 1;99(7):395-401. doi: 10.1002/jso.21281.
6
Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.大体Borrmann分型作为进展期胃癌患者的一个简单预后指标。
Oncology. 2009;77(3-4):197-204. doi: 10.1159/000236018. Epub 2009 Sep 3.
7
Comparison of prognostic scoring system to tumor node metastases 1992 and 1997 staging systems in gastric cancer patients.胃癌患者预后评分系统与1992年和1997年肿瘤淋巴结转移分期系统的比较。
Neoplasma. 2002;49(5):323-8.
8
[The prognostic analysis of tumor size in T4a stage gastric cancer].[T4a期胃癌肿瘤大小的预后分析]
Zhonghua Wai Ke Za Zhi. 2013 Mar;51(3):230-4.
9
Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.进展期胃癌中大体浆膜侵犯的预后意义
Hepatogastroenterology. 2007 Oct-Nov;54(79):2028-31.
10
[Prognosis analysis of 310 patients with pathological stage pN3 gastric cancer].310例病理分期为pN3的胃癌患者的预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jun;16(6):543-6.

引用本文的文献

1
Oncological similarities between large type 3 and type 4 tumors in patients with resectable gastric cancer: a propensity score-matched analysis of a multi-institutional dataset.可切除胃癌中大型 3 型和 4 型肿瘤的肿瘤学相似性:多机构数据集的倾向评分匹配分析。
Gastric Cancer. 2024 Nov;27(6):1331-1341. doi: 10.1007/s10120-024-01546-x. Epub 2024 Aug 22.
2
Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer.基于术前纤维蛋白原和全身免疫炎症指数的列线图预测Borrmann III型进展期胃癌患者的复发和预后
J Inflamm Res. 2023 Mar 12;16:1059-1075. doi: 10.2147/JIR.S404585. eCollection 2023.
3
Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer.
AADAC 基因表达对 Borrmann Ⅲ型进展期胃癌患者预后的影响。
BMC Cancer. 2022 Jun 9;22(1):635. doi: 10.1186/s12885-022-09594-1.
4
Re-emerging role of macroscopic appearance in treatment strategy for gastric cancer.宏观表现在胃癌治疗策略中的重新凸显作用。
Ann Gastroenterol Surg. 2018 Oct 19;3(2):122-129. doi: 10.1002/ags3.12218. eCollection 2019 Mar.
5
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.一项新辅助化疗联合多西他赛、顺铂和 S-1,继以 D2 淋巴结清扫术治疗高危进展期胃癌的 II 期研究:KDOG1001 试验结果。
Gastric Cancer. 2019 May;22(3):598-606. doi: 10.1007/s10120-018-0884-0. Epub 2018 Oct 3.
6
Macroscopic appearance of Type IV and giant Type III is a high risk for a poor prognosis in pathological stage II/III advanced gastric cancer with postoperative adjuvant chemotherapy.在接受术后辅助化疗的病理II/III期进展期胃癌中,IV型和巨大III型的宏观表现提示预后不良风险较高。
World J Gastrointest Oncol. 2017 Apr 15;9(4):166-175. doi: 10.4251/wjgo.v9.i4.166.
7
DNA diagnosis of peritoneal fluid cytology test by CDO1 promoter DNA hypermethylation in gastric cancer.胃癌腹腔液细胞学检测中 CDO1 启动子 DNA 超甲基化的 DNA 诊断。
Gastric Cancer. 2017 Sep;20(5):784-792. doi: 10.1007/s10120-017-0697-6. Epub 2017 Feb 27.
8
Limited significance of curative surgery in Borrmann type IV gastric cancer.Borrmann IV型胃癌根治性手术的意义有限。
Med Oncol. 2016 Jul;33(7):69. doi: 10.1007/s12032-016-0783-3. Epub 2016 Jun 1.